EBMeDS: Evidence-Based Medicine Electronic Decision Support Study

Sponsor

Tampere University (Other)

Overall Status

Completed

CT.gov ID

NCT00915304

Collaborator

The Finnish Medical Society Duodecim (Other), Finnish Institute for Health and Welfare (Other), Duodecim Medical Publications Ltd. (Industry), ProWellness Ltd. (Other), The Finnish Funding Agency for Technology and Innovation (TEKES) (Other)

12,101

Enrollment

Location

Duration (Months)

603.8

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to analyze the effect of the Evidence-Based Medicine electronic Decision Support (EBMeDS) automatic reminders in primary health care.

Hypothesis (1)is that in the intervention group the total number of EBMeDS reminders will decrease compared to the control group.

Hypothesis (2) is that in the intervention group the quality measures will increase faster compared to the control group at follow-up time.

Condition or Disease	Intervention/Treatment	Phase
Decision Support Systems, Clinical	Behavioral: The EBMeDS reminders	Phase 1/Phase 2

Study Design

Study Type:

Interventional

Actual Enrollment :

12101 participants

Allocation:

Randomized

Intervention Model:

Single Group Assignment

Masking:

Double (Participant, Investigator)

Primary Purpose:

Health Services Research

Official Title:

Patient Specific Automatic Reminders in Primary Care - the EBMeDS Randomised Trial

Study Start Date :

Jun 1, 2009

Actual Primary Completion Date :

Feb 1, 2011

Actual Study Completion Date :

Feb 1, 2011

Outcome Measures

Primary Outcome Measures

The number of reminders triggered (in relation to the number of eligible patients, Ri/Ni) during repeated Virtual Health Checks (VHCs) [Follow-up time max one and half year]
VHC will be performed once a week for the whole study population, beginning at baseline and before randomisation. The main outcome measure is Ri/Ni at follow-up time after commencement of the study where Ri is the total number of reminders triggered by the patient record data in intervention and in control group at the time of analysis, and Ni is the total number of patients.

Secondary Outcome Measures

Specific clinical measures compared to an intervention and a control group []
Clinical measures as mean values of laboratory parameters, for example a mean level of HbA1c, a mean level of total cholesterol.

Eligibility Criteria

Criteria

Ages Eligible for Study:

N/A and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

All residents of Sipoo who have patient ID number in the Mediatri electronic patient record system in Sipoo Health Centre

Exclusion Criteria:

Those residents who's occupational health care is produced by Sipoo Health Centre

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	University of Tampere; School of Health Sciences	Tampere		Finland	33014

Sponsors and Collaborators

Tampere University
The Finnish Medical Society Duodecim
Finnish Institute for Health and Welfare
Duodecim Medical Publications Ltd.
ProWellness Ltd.
The Finnish Funding Agency for Technology and Innovation (TEKES)

Investigators

Study Director: Pekka Rissanen, Professor, University of Tampere; School of Health Sciences
Principal Investigator: Tiina Kortteisto, MSc, University of Tampere; School of Health Sciences